V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10182573 | 10054917 | 1.84 | 75.1 | null | 2021-06-04 | 2021-06-10 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100852568 |
| 10183467 | 10054919 | 1.71 | 0 | null | 2019-09-14 | 2020-01-01 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100861028 |
| 10183708 | 10054920 | 1.73 | 86 | null | 2017-02-05 | 2017-05-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100426929 |
| 10184840 | 10054922 | 1.75 | 61.6 | null | null | 2016-06-21 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 100263333 |
| 10185620 | 10054923 | 1.78 | 77 | null | null | 2020-11-13 | Avelumab | 02 | null | AVELUMAB | 100948685 |
| 10186199 | 10054924 | 1.42 | 56.4 | Disease modification (D) | 2019-04-22 | 2019-05-20 | Avelumab | 02 | N | AVELUMAB | 101743237 |
| 10188153 | 10054925 | null | 77.3 | Adjuvant (A) | null | 2017-03-06 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101753439 |
| 10190469 | 10054926 | 0 | 89.7 | Palliative (P) | 2019-11-12 | 2022-02-27 | RUXOLITINIB | 02 | N | RUXOLITINIB | 101581858 |
| 10191357 | 10054927 | 1.73 | 61.8 | 03 | null | 2020-01-20 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100572795 |
| 10191509 | 10054928 | 1.88 | 86.25 | null | 2016-01-31 | 2016-02-08 | Trastuzumab 21 day loading dose | 02 | null | TRASTUZUMAB | 101737962 |
| 10192451 | 10054929 | 1.54 | 73.7 | Palliative (P) | 2020-11-06 | 2021-04-01 | Venetoclax | 02 | N | VENETOCLAX | 100690251 |
| 10192850 | 10054930 | 1.61 | 113 | null | 2020-07-31 | 2020-08-04 | Avelumab | 02 | null | AVELUMAB | 101157011 |
| 10192863 | 10054931 | 1.46 | 61 | 03 | 2017-09-03 | 2017-10-20 | Avelumab | 02 | null | BENDAMUSTINE + RITUXIMAB | 100364497 |
| 10193007 | 10054932 | 1.63 | 159 | Palliative (P) | 2021-06-21 | 2021-07-04 | Oxaliplatin + Modified de Gramont | 02 | N | FLUOROURACIL + OXALIPLATIN | 101474951 |
| 10193013 | 10054933 | 1.75 | 64 | Palliative (P) | null | 2018-07-04 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE + OXALIPLATIN | 100757123 |
| 10193283 | 10054934 | 0 | null | Palliative (P) | 2018-12-11 | 2018-12-18 | Bendamustine+Rituximab(Sub Courses) | 02 | null | BENDAMUSTINE + RITUXIMAB | 101634056 |
| 10194450 | 10054935 | 1.7 | 64.8 | null | 2016-01-06 | 2016-02-26 | Avelumab | 02 | null | RUXOLITINIB | 100889408 |
| 10195063 | 10054936 | 1.74 | 67 | Palliative (P) | 2020-07-31 | 2020-08-18 | Avelumab | 02 | N | BENDAMUSTINE + RITUXIMAB | 101337089 |
| 10195441 | 10054937 | 0 | 52.1 | null | 2016-09-02 | 2016-09-02 | BENDAMUSTINE + RITUXIMAB | 02 | null | BENDAMUSTINE + RITUXIMAB | 100963537 |
| 10196159 | 10054938 | 1.76 | 110 | null | 2017-09-10 | 2017-09-19 | Venetoclax | 02 | null | VENETOCLAX | 100646817 |
| 10197738 | 10054939 | 1.8 | null | Neo-adjuvant (N) | 2021-10-25 | 2021-10-26 | Avelumab | 02 | N | FLUOROURACIL + IRINOTECAN | 100371119 |
| 10198299 | 10054940 | 1.73 | 55 | null | 2020-04-10 | 2020-05-27 | Avelumab | 02 | null | DARATUMUMAB | 100140889 |
| 10198429 | 10054941 | null | 57.6 | null | 2021-08-01 | 2021-08-23 | Avelumab | 02 | null | NIVOLUMAB | 100216403 |
| 10199026 | 10054942 | 1.69 | 86.6 | null | null | 2019-06-19 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100144881 |
| 10199173 | 10054943 | 1.7 | 71 | Palliative (P) | 2020-02-28 | 2020-03-20 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100413893 |
| 10200478 | 10054944 | 1.71 | 105 | Curative (C) | 2019-11-23 | 2019-12-17 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101586773 |
| 10200738 | 10054945 | 1.55 | 67.9 | null | null | 2017-07-31 | CEMIPLIMAB | 02 | null | CEMIPLIMAB | 101714519 |
| 10201751 | 10054946 | 1.54 | null | null | null | 2021-02-24 | Avelumab | 02 | null | VENETOCLAX | 100266172 |
| 10201773 | 10054947 | null | 83 | Palliative (P) | null | 2019-06-10 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101630524 |
| 10203444 | 10054948 | 1.76 | 73.2 | Adjuvant (A) | 2018-08-19 | 2018-08-31 | Venetoclax | 02 | N | VENETOCLAX | 101769905 |
| 10204783 | 10054951 | 1.59 | 58 | null | 2019-01-17 | 2019-01-17 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100273950 |
| 10205020 | 10054952 | 1.64 | 72.5 | null | 2022-03-29 | 2022-04-10 | Avelumab | 02 | null | DARATUMUMAB | 100729063 |
| 10205217 | 10054954 | 1.58 | 98 | null | 2016-10-11 | 2017-10-01 | Venetoclax | 02 | null | VENETOCLAX | 101588175 |
| 10205376 | 10054957 | 1.63 | 62.35 | null | 2017-08-26 | 2017-08-26 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100052972 |
| 10205421 | 10054958 | 1.68 | 101.3 | null | null | 2020-06-25 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100700675 |
| 10205765 | 10054960 | 1.62 | 55 | 03 | 2019-05-01 | 2019-05-20 | FLUOROURACIL + OXALIPLATIN | 02 | N | FLUOROURACIL + IRINOTECAN | 101215653 |
| 10205798 | 10054961 | 1.71 | 86.1 | Palliative (P) | null | 2021-05-25 | Bendamustine+Rituximab (1st Course) | 02 | N | BENDAMUSTINE + RITUXIMAB | 100521409 |
| 10205839 | 10054962 | 1.61 | 79.4 | Palliative (P) | null | 2021-01-02 | DARATUMUMAB | 02 | N | DARATUMUMAB | 101001615 |
| 10206060 | 10054964 | 1.62 | 66.8 | null | null | 2019-10-22 | CEMIPLIMAB | 02 | N | VENETOCLAX | 100933397 |
| 10206452 | 10054965 | null | 56 | null | null | 2017-07-22 | Avelumab | 02 | null | FLUOROURACIL + OXALIPLATIN | 100500639 |
| 10206731 | 10054966 | 1.75 | 109 | null | 2018-01-26 | 2018-03-15 | Avelumab | 02 | null | TRASTUZUMAB | 100972675 |
| 10206789 | 10054967 | 1.67 | 75.6 | Neo-adjuvant (N) | 2016-04-28 | 2016-05-05 | Avelumab | 02 | N | AVELUMAB | 101527823 |
| 10207064 | 10054968 | null | 47.6 | Palliative (P) | 2019-06-08 | 2019-08-04 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100214072 |
| 10207627 | 10054969 | 1.61 | 76 | Neo-adjuvant (N) | null | 2021-05-31 | RUXOLITINIB | 02 | N | RUXOLITINIB | 100603701 |
| 10207631 | 10054970 | 1.71 | 46.6 | null | 2015-08-22 | 2020-04-08 | RUXOLITINIB | null | N | RUXOLITINIB | 101054565 |
| 10207709 | 10054971 | 1.62 | 67.4 | null | 2020-04-20 | 2020-08-25 | DARATUMUMAB | 02 | N | DARATUMUMAB | 100467553 |
| 10207971 | 10054972 | 1.77 | 54 | Palliative (P) | 2019-01-02 | 2019-02-22 | Venetoclax | 02 | N | VENETOCLAX | 100573520 |
| 10208197 | 10054974 | 1.49 | 72.75 | 03 | 2017-03-31 | 2017-07-08 | Irinotecan + Modified De Gramont | 02 | N | FLUOROURACIL + IRINOTECAN | 101333090 |
| 10208401 | 10054977 | 1.7 | 74.6 | null | 2019-05-19 | 2019-08-05 | NIVOLUMAB | 02 | null | VENETOCLAX | 101611354 |
| 10208505 | 10054978 | 1.62 | 78.6 | Palliative (P) | null | 2019-05-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101005519 |